Cargando…
Exploration of a Novel Prognostic Nomogram and Diagnostic Biomarkers Based on the Activity Variations of Hallmark Gene Sets in Hepatocellular Carcinoma
BACKGROUND: The initiation and progression of tumors were due to variations of gene sets rather than individual genes. This study aimed to identify novel biomarkers based on gene set variation analysis (GSVA) in hepatocellular carcinoma. METHODS: The activities of 50 hallmark pathways were scored in...
Autores principales: | Zhong, Xiongdong, Yu, Xianchang, Chang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960170/ https://www.ncbi.nlm.nih.gov/pubmed/35359370 http://dx.doi.org/10.3389/fonc.2022.830362 |
Ejemplares similares
-
Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma
por: Fang, Qiongxuan, et al.
Publicado: (2020) -
Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers
por: An, Shu, et al.
Publicado: (2023) -
Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization
por: Xu, Jing-Xuan, et al.
Publicado: (2023) -
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
por: Hu, Chuan, et al.
Publicado: (2020) -
CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
por: Cai, Chenhui, et al.
Publicado: (2021)